Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multi-center Clinical Study：Bevacizumab for Neovascular Age-related Macular Degeneration

NCT01306591 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT01306591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01306591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multi-center Clinical Study：Bevacizumab for Neovascular Age-related Macular Degeneration
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2008
Completion date
December 31, 2010
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exudative age-related macular degeneration